Catheter ablation of typical and atypical atrial flutters in a patient with transcatheter tricuspid valve replacement

Tricuspid regurgitation (TR) is a common form of valvular heart disease, and has been associated with adverse outcomes including heart failure and an increased risk of mortality.1 This may be particularly true in patients with coexisting atrial arrhythmias.2,3 Surgical management of isolated TR has traditionally been avoided due to relatively high surgical risk.4 Recently, transcatheter tricuspid valve replacement (TTVR) using the EVOQUE system has shown promise as a safe and effective treatment for patients with severe TR.